Latest Healthcare Research Reports

Tag: diabetes care devices market trends

  • Diabetes Treatment Devices Market Growth Potential: What The Latest Forecast Reveals

    Diabetes Treatment Devices Market Growth Potential: What The Latest Forecast Reveals

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Diabetes Treatment Devices Market Value Growth And Long-Term Outlook

    The diabetes treatment devices market size has shown significant growth in recent years. It is anticipated to increase from $12.34 billion in 2025 to $13.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. Historically, this growth can be attributed to the reliance on traditional blood glucose meters, a limited understanding of self-monitoring devices, the expansion of hospital and diagnostic center infrastructure, the rising occurrence of diabetes, and the widespread use of standard lancets and testing strips.

    The diabetes treatment devices market is set to observe significant expansion over the next few years. It is predicted to attain a value of $16.53 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.0%. This anticipated growth throughout the forecast period stems from factors such as the creation of smart insulin pens and pumps, the increasing adoption of real-time continuous glucose monitoring, the merging of technology with smartphones and wearable devices, the growth of remote patient monitoring initiatives, and the enlargement of diabetes clinics alongside online distribution channels. Prominent trends expected in this period include the escalating uptake of continuous glucose monitoring devices, a rising preference for intelligent insulin delivery systems, an increase in homecare and remote patient observation, the wider availability of wearable and portable glucometers, and an enhanced demand for safety-improved lancets and testing strips.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=74774479&type=smp&name=Diabetes%20Treatment%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Diabetes Treatment Devices Market Demand Drivers: What’s Powering Industry Growth?

    The rising prevalence of obesity is projected to stimulate the expansion of the diabetes treatment devices market in the future. Obesity rate defines the proportion of individuals categorized as obese based on their body mass index (BMI). The growing obesity levels are primarily caused by unhealthy eating patterns rich in calories, sugars, and fats, leading to excessive weight gain when not balanced by physical activity. Diabetes treatment devices assist in reducing obesity rates by fostering improved blood sugar control, which in turn supports healthier lifestyle choices and weight management. For instance, in September 2024, according to the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, adult obesity rates reached 35% or more in 23 US states in 2023, an increase from 22 states in 2022, indicating a worsening obesity situation. Therefore, increasing obesity rates are propelling the growth of the diabetes treatment devices market.

    Diabetes Treatment Devices Market Segment Outlook: Which Categories Are Growing Fastest?

    The diabetes treatment devices market covered in this report is segmented –

    1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

    3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

    Subsegments:

    1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

    2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

    3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

    4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

    5) By Lancets: Standard Lancets, Safety Lancets

    6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

    7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

    8) By Transmitters: Reusable Transmitters, Disposable Transmitters

    9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

    10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

    Diabetes Treatment Devices Market Innovation Trends: What Developments Are Reshaping The Industry?

    Leading firms within the diabetes treatment devices market are prioritizing the integration of sophisticated automation technologies, including automated insulin delivery algorithms, to boost the accuracy of treatment and maintain consistent glycemic control. Such algorithms utilize live glucose readings from continuous glucose monitoring sensors to automatically modify basal insulin dosages, thereby assisting in keeping glucose levels within the desired range with very little manual input. A notable example is Medtronic plc, a medical technology firm from the US, which secured FDA approval in April 2023 for its MiniMed 780G System. This automated insulin delivery technology aims to aid those with type 1 diabetes by automatically rectifying high glucose levels and adjusting insulin delivery every five minutes. The system incorporates SmartGuard technology for insulin adjustments that respond to real-time glucose changes, offers Bluetooth connectivity for mobile observation, and includes built-in continuous glucose monitoring support. The MiniMed 780G System contributes to enhanced treatment accuracy, greater glucose stability, and improved daily diabetes management results.

    Diabetes Treatment Devices Market Competitive Landscape: Who Leads The Industry?

    Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

    View The Full Diabetes Treatment Devices Market Report:

    https://thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Diabetes Treatment Devices Market Geographic Landscape: Which Region Dominates Industry Growth?

    North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Care Devices Market Growth Outlook: Why Analysts Expect Continued Expansion

    Diabetes Care Devices Market Growth Outlook: Why Analysts Expect Continued Expansion

    Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

    Diabetes Care Devices Market Poised To Hit $130.76 Billion By 2030 With A 12.3% CAGR

    The diabetes care devices market size has seen significant rapid expansion in recent years. This market is expected to expand from $73.91 billion in 2025 to $82.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.3%. Several factors contributed to this historical growth, including the increasing global prevalence of diabetes, enhanced access to glucose monitoring devices, the expansion of outpatient diabetes care services, greater awareness of self-monitoring practices, and the rising availability of disposable testing supplies.

    The diabetes care devices market is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $130.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This projected growth can be attributed to a heightened demand for real-time glucose monitoring, the increasing uptake of closed-loop insulin systems, the broadening reach of digital diabetes management platforms, a sharpened emphasis on individualized diabetes care, and increased healthcare investments dedicated to chronic disease management. Key trends during this period are expected to encompass the growing acceptance of continuous glucose monitoring devices, an increase in the utilization of smart insulin delivery systems, the deeper integration of mobile health platforms, the broadening of connected diabetes management ecosystems, and a greater concentration on patient-focused monitoring solutions.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=39718479&type=smp&name=Diabetes%20Care%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Diabetes Care Devices Market Growth Drivers: What’s Behind The Acceleration?

    The diabetes care device market is projected to expand in the future, driven by increasing healthcare expenditures. Healthcare expenditures encompass the total amount spent on health-related services, products, and activities over a specific period, typically at an individual, community, national, or global level. This rise in healthcare spending, combined with enhanced access to healthcare services and a growing number of diabetes diagnoses, stimulates increased investments in research and development. This ultimately leads to advancements in diabetes care devices, such as improved glucose monitoring systems, insulin delivery mechanisms, and digital health solutions. For example, in June 2025, the Centers for Medicare & Medicaid Services (CMS), a U.S. federal agency, reported that National Health Expenditure (NHE) grew by 7.5% to $4.9 trillion in 2023, amounting to $14,570 per person, and accounted for 17.6% of Gross Domestic Product (GDP). Hospital expenditures also rose by 10.4% to $1,519.7 billion in 2023, a faster rate than the 3.2% growth recorded in 2022. Therefore, the continuous increase in healthcare expenditure is anticipated to fuel the growth of the diabetes care device market going forward.

    Diabetes Care Devices Market Segment Landscape: Which Areas Lead Development?

    The diabetes care devices market covered in this report is segmented –

    1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters

    2) By Type of Expenditure: Public, Private

    3) By Consumable Type: Instruments Or Equipment, Disposables

    4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing

    5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

    Subsegments:

    1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors

    2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens

    3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes

    4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps

    5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges)

    6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters

    7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management

    Diabetes Care Devices Market Trends: What’s Defining The Industry’s Next Phase?

    Leading firms within the diabetes care devices market are prioritizing the creation of sophisticated solutions, including real-time glucose monitoring technology, to elevate precision, user convenience, and proactive disease control. This real-time glucose monitoring system delivers automated, ongoing glucose readings and notifications, empowering individuals with diabetes to make prompt choices and mitigate potential health hazards. An illustrative example is seen in August 2025, when Abbott Laboratories, a healthcare company based in the US, introduced the FreeStyle Libre 2 Plus. This innovation provides continuous, minute-by-minute glucose data transmitted directly to a compatible smartphone, alongside customizable alerts for instances of low or high glucose levels. The device facilitates assured self-management of diabetes by supplying automated alerts, insights into historical trends, and directional indicators, thereby eliminating the need for regular fingerstick tests. Utilizing near-field communication and Bluetooth connectivity, it functions effectively and is designed for wear for a duration of up to 15 days. Furthermore, it permits caregivers to obtain glucose status updates via integrated digital health platforms. This device contributes to enhanced patient safety through facilitating rapid interventions and boosts user engagement by offering real-time data that informs everyday health decisions.

    Diabetes Care Devices Market Company Landscape And Competitive Strategy

    Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited

    View The Full Diabetes Care Devices Market Report:

    https://thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Diabetes Care Devices Market Largest Region: Which Geography Holds The Highest Market Share?

    North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Treatment Devices Market Forecast Covering Industry Demand And Market Evolution

    Diabetes Treatment Devices Market Forecast Covering Industry Demand And Market Evolution

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Is The Expected Market Size Of The Diabetes Treatment Devices Market In 2026 And How Much Will It Reach By 2030?

    The diabetes treatment devices market has demonstrated strong growth in recent years. This market is expected to expand from $12.34 billion in 2025 to $13.11 billion in 2026, at a compound annual growth rate (CAGR) of 6.2%. The historical increase can be attributed to factors such as reliance on traditional blood glucose meters, limited awareness of self-monitoring devices, expanding hospital and diagnostic center infrastructure, the increasing prevalence of diabetes, and the adoption of standard lancets and testing strips.

    The diabetes treatment devices market is projected to experience substantial growth in the upcoming years. This market is anticipated to reach $16.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. The forecasted growth is primarily driven by advancements such as smart insulin pens and pumps, the growing embrace of real-time continuous glucose monitoring, seamless integration with smartphones and wearables, the proliferation of remote patient monitoring initiatives, and the expansion of specialized diabetes clinics and online retail channels. Key trends expected during this period involve the increasing uptake of continuous glucose monitoring devices, a rising preference for intelligent insulin delivery systems, an expansion of homecare and remote patient monitoring solutions, the broadening use of wearable and handheld glucometers, and an elevated demand for improved safety lancets and testing strips.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

    What Primary Factors Are Fueling The Expansion Of The Diabetes Treatment Devices Market?

    The rising prevalence of obesity is anticipated to boost the expansion of the diabetes treatment devices market going forward. The obesity rate indicates the proportion of individuals categorized as obese based on their body mass index (BMI). A major contributor to these increasing rates is unhealthy eating patterns, rich in calories, sugars, and fats, which result in significant weight gain when not combined with physical activity. Diabetes treatment devices contribute to lowering obesity rates by encouraging improved blood sugar regulation, thereby fostering healthier lifestyle choices and weight control. For example, in September 2024, data from the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, showed that in 2023, adult obesity rates were 35% or higher in 23 US states, an increase from 22 states in 2022, signaling an escalating obesity problem. Consequently, the growing obesity rates are a key factor propelling the development of the diabetes treatment devices market.

    What Are The Major Segment Categories Within The Diabetes Treatment Devices Market?

    The diabetes treatment devices market covered in this report is segmented –

    1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

    3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

    Subsegments:

    1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

    2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

    3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

    4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

    5) By Lancets: Standard Lancets, Safety Lancets

    6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

    7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

    8) By Transmitters: Reusable Transmitters, Disposable Transmitters

    9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

    10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

    What Trends Are Influencing The Diabetes Treatment Devices Market?

    Leading companies operating within the diabetes treatment devices market are increasingly focusing on incorporating advanced automation technologies, such as automated insulin delivery algorithms, to enhance treatment precision and achieve continuous glycemic control. These algorithms leverage real-time glucose data from continuous glucose monitoring sensors to automatically adjust basal insulin dosing, thereby assisting in maintaining glucose levels within the target range with minimal manual intervention. For example, in April 2023, Medtronic plc, a US-based medical technology company, obtained FDA approval for the MiniMed 780G System. This automated insulin delivery technology is specifically designed to support individuals with type 1 diabetes by automatically correcting highs and adjusting insulin delivery every five minutes. The system features SmartGuard technology for real-time, glucose-responsive insulin adjustments, includes Bluetooth connectivity for mobile monitoring, and offers integrated continuous glucose monitoring support. The MiniMed 780G System improves treatment accuracy, enhances glucose stability, and optimizes day-to-day diabetes management outcomes.

    Who Are The Leading Firms Participating In The Diabetes Treatment Devices Market?

    Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

    Access The Complete Diabetes Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

    What Is The Largest Regional Market In The Diabetes Treatment Devices Market?

    North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Customized Diabetes Treatment Devices Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

    Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2026, By The Business Research Company

    Pet Diabetes Care Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

    Insulin Delivery Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

    Continuous Glucose Monitoring Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Care Devices Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

    Diabetes Care Devices Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Market Size Is Forecasted For The Diabetes Care Devices Market By 2030 Based On Its 2026 Value?

    The market size for diabetes care devices has experienced rapid expansion in recent years. It is projected to grow from $73.91 billion in 2025 to $82.22 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.3%. The growth observed in the historic period can be attributed to factors such as rising global diabetes prevalence, improved access to glucose monitoring devices, the expansion of outpatient diabetes care, increased awareness of self-monitoring practices, and the growing availability of disposable testing supplies.

    The diabetes care devices market size is projected to experience rapid expansion over the next few years. It is expected to reach $130.76 billion in 2030, with a compound annual growth rate (CAGR) of 12.3%. This growth during the forecast period can be attributed to factors such as increasing demand for real-time glucose monitoring, rising adoption of closed-loop insulin systems, the expansion of digital diabetes management platforms, a growing focus on personalized diabetes care, and increasing healthcare investments in chronic disease management. Major trends anticipated in the forecast period include the increasing adoption of continuous glucose monitoring devices, the rising use of smart insulin delivery systems, growing integration of mobile health platforms, the expansion of connected diabetes management ecosystems, and an enhanced focus on patient-centric monitoring solutions.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3609&type=smp

    Which Strategic Drivers Are Supporting The Diabetes Care Devices Market Development?

    Higher spending on healthcare is expected to fuel the expansion of the diabetes care device market in the future. Healthcare expenditures represent the comprehensive sum dedicated to services, products, and activities related to healthcare over a defined timeframe, applicable to individuals, communities, nations, or globally. This surge in healthcare spending, combined with improved access to medical services and an increase in diabetes diagnoses, encourages greater investments in research and development. This, in turn, fosters the development of advanced diabetes care devices like enhanced glucose monitoring systems, sophisticated insulin delivery devices, and innovative digital health solutions. To illustrate, in June 2025, data from the Centers for Medicare & Medicaid Services (CMS), a US federal agency, showed that National Health Expenditure (NHE) increased by 7.5%, reaching $4.9 trillion in 2023, equating to $14,570 per person, and constituting 17.6% of the Gross Domestic Product (GDP). Furthermore, hospital expenditures saw a rise of 10.4% to $1,519.7 billion in 2023, which outpaced the 3.2% growth observed in 2022. Consequently, the escalation in healthcare spending is set to stimulate the expansion of the diabetes care device market in the coming period.

    How Is The Diabetes Care Devices Market Distributed Across Key Segments?

    The diabetes care devices market covered in this report is segmented –

    1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters

    2) By Type of Expenditure: Public, Private

    3) By Consumable Type: Instruments Or Equipment, Disposables

    4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing

    5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

    Subsegments:

    1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors

    2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens

    3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes

    4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps

    5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges)

    6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters

    7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management

    Which Trends Are Guiding The Development Of The Diabetes Care Devices Market?

    Leading corporations within the diabetes care devices market are focusing on developing sophisticated solutions, such as real-time glucose monitoring technology, to improve accuracy, convenience, and proactive disease management. This real-time glucose monitoring technology delivers automatic, continuous glucose readings and alerts, assisting individuals with diabetes in making timely decisions and mitigating health risks. For example, in August 2025, Abbott Laboratories, a US-based healthcare company, introduced the FreeStyle Libre 2 Plus, which features uninterrupted minute-by-minute glucose readings transmitted directly to a compatible smartphone, alongside optional alarms for low or high glucose events. The device supports assured diabetes self-management by offering automated alerts, historical trends, and directional arrows, thereby eliminating the need for routine fingersticks. It operates using near-field communication and Bluetooth connectivity and is wearable for up to 15 days. Moreover, it empowers caregivers to receive glucose updates via integrated digital health tools. The device contributes to enhanced patient safety by enabling swift interventions and boosts engagement through providing real-time insights that guide daily health choices.

    Which Companies Are Engaged In The Diabetes Care Devices Market Environment?

    Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited

    Access The Complete Diabetes Care Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

    Which Region Contributes The Most To The Diabetes Care Devices Market?

    North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Customized Diabetes Care Devices Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=3609&type=smp

    Browse Through More Reports Similar to the Global Diabetes Care Devices Market 2026, By The Business Research Company

    Pet Diabetes Care Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

    Insulin Delivery Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

    Digital Diabetes Management Market Report 2026

    https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Diabetes Treatment Devices Market Analysis For 2026–2030 With Strategic Insights

    Global Diabetes Treatment Devices Market Analysis For 2026–2030 With Strategic Insights

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    From Its 2026 Market Size, What Value Is The Diabetes Treatment Devices Market Projected To Reach By 2030?

    The market for diabetes treatment devices has experienced substantial growth in recent years. This market is projected to expand from $12.34 billion in 2025 to $13.11 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.2%. Historically, this expansion has been driven by factors such as the dependence on conventional blood glucose meters, a restricted understanding of self-monitoring devices, the expansion of hospital and diagnostic center infrastructure, the rising incidence of diabetes, and the widespread use of standard lancets and testing strips.

    The market for diabetes treatment devices is projected to experience substantial expansion over the coming years. This market is anticipated to reach $16.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. The anticipated growth during this period stems from several factors, including the advancement of smart insulin pens and pumps, the growing uptake of real-time continuous glucose monitoring, their integration with smartphones and wearable technologies, the proliferation of remote patient monitoring initiatives, and the expansion of diabetes clinics along with online distribution avenues. Key trends foreseen for the forecast horizon encompass the escalating adoption of continuous glucose monitoring devices, a growing inclination towards smart insulin delivery systems, an increase in homecare and remote patient monitoring, the broader availability of wearable and handheld glucometers, and an elevated demand for safety-improved lancets and testing strips.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

    Which Primary Drivers Are Impacting The Diabetes Treatment Devices Market Growth?

    The future growth of the diabetes treatment devices market is expected to be propelled by increasing obesity rates. The obesity rate indicates the percentage of individuals classified as obese based on their body mass index (BMI). These rising obesity rates are primarily a result of unhealthy diets, rich in calories, sugars, and fats, which cause excessive weight gain when not balanced with physical activity. Diabetes treatment devices contribute to reducing obesity rates by fostering better blood sugar control, thereby supporting healthier lifestyle habits and weight management. For instance, in September 2024, data from the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, revealed that in 2023, adult obesity rates reached 35% or higher in 23 US states, an increase from 22 states in 2022, highlighting a deteriorating obesity trend. Therefore, the rise in obesity rates is a key driver for the expansion of the diabetes treatment devices market.

    How Are Different Segments Classified In The Diabetes Treatment Devices Market Segment Analysis?

    The diabetes treatment devices market covered in this report is segmented –

    1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

    3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

    Subsegments:

    1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

    2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

    3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

    4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

    5) By Lancets: Standard Lancets, Safety Lancets

    6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

    7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

    8) By Transmitters: Reusable Transmitters, Disposable Transmitters

    9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

    10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

    Which Trends Are Shaping Growth In The Diabetes Treatment Devices Market?

    Leading firms within the diabetes treatment devices market are prioritizing the integration of sophisticated automation technologies, including automated insulin delivery algorithms, to improve the accuracy of treatment and ensure consistent glycemic management. Such algorithms leverage real-time glucose information from continuous glucose monitoring sensors to autonomously modify basal insulin doses, thereby assisting in keeping glucose levels within the desired range with very little human involvement. As an example, in April 2023, Medtronic plc, a medical technology company based in the US, secured FDA approval for its MiniMed 780G System, which is an automated insulin delivery solution intended to assist people with type 1 diabetes by automatically rectifying high glucose levels and adjusting insulin delivery every five minutes. This system incorporates SmartGuard technology for insulin adjustments that respond to glucose levels in real-time, offers Bluetooth connectivity for convenient mobile monitoring, and provides integrated continuous glucose monitoring capabilities. The MiniMed 780G System enhances the precision of treatment, promotes glucose stability, and leads to better daily diabetes management results.

    Who Are The Companies Driving Activity In The Diabetes Treatment Devices Market?

    Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

    Get The Full Diabetes Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

    Which Region Has The Greatest Market Share In The Diabetes Treatment Devices Market?

    North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Diabetes Treatment Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

    Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2026, By The Business Research Company

    Pet Diabetes Care Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

    Insulin Delivery Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

    Continuous Glucose Monitoring Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Care Devices Market Outlook 2026–2030 Driven By Growth Factors And Projections

    Diabetes Care Devices Market Outlook 2026–2030 Driven By Growth Factors And Projections

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Much Growth In Market Value Is Expected For The Diabetes Care Devices Market Between 2026 And 2030?

    The diabetes care devices market size has experienced rapid growth in recent years. It is anticipated to expand from $73.91 billion in 2025 to $82.22 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.3%. The historical expansion of this market can be attributed to factors such as the rising global diabetes prevalence, improved access to glucose monitoring devices, the expansion of outpatient diabetes care, increased awareness of self-monitoring practices, and the growing availability of disposable testing supplies.

    The diabetes care devices market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $130.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.3%. This projected growth stems from several factors, including the escalating need for real-time glucose monitoring, the rising uptake of closed-loop insulin systems, the broadening of digital diabetes management platforms, a heightened emphasis on personalized diabetes care, and increased healthcare spending in chronic disease management. Key developments expected during this period involve a greater embrace of continuous glucose monitoring devices, increased utilization of smart insulin delivery systems, deeper integration of mobile health platforms, the growth of interconnected diabetes management ecosystems, and a stronger focus on patient-centered monitoring solutions.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3609&type=smp

    What Significant Factors Are Influencing The Diabetes Care Devices Market Expansion?

    Rising healthcare spending is anticipated to drive the expansion of the diabetes care device market in the coming years. Healthcare expenditures encompass the total funds allocated for healthcare-related services, products, and activities over a specified duration, typically evaluated at an individual, community, national, or global level. This increase in healthcare expenditures, alongside improved access to healthcare services and a growing number of diabetes diagnoses, encourages greater investment in research and development, which facilitates the advancement of diabetes care devices such as enhanced glucose monitoring systems, insulin delivery devices, and digital health solutions. For example, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, National Health Expenditure (NHE) rose by 7.5% to $4.9 trillion in 2023, or $14,570 per person, and accounted for 17.6% of Gross Domestic Product (GDP). Hospital expenditures increased by 10.4% to $1,519.7 billion in 2023, outpacing the 3.2% growth seen in 2022. Therefore, increasing healthcare expenditure will propel the growth of the diabetes care device market going forward.

    How Is The Diabetes Care Devices Market Categorized Across Its Segment Groups?

    The diabetes care devices market covered in this report is segmented –

    1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters

    2) By Type of Expenditure: Public, Private

    3) By Consumable Type: Instruments Or Equipment, Disposables

    4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing

    5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

    Subsegments:

    1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors

    2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens

    3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes

    4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps

    5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges)

    6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters

    7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management

    What Trends Are Affecting The Direction Of The Diabetes Care Devices Market?

    Leading firms within the diabetes care devices market are concentrating on creating sophisticated solutions, including real-time glucose monitoring technology, to improve precision, ease of use, and proactive disease management. This real-time glucose monitoring capability offers automated, continuous glucose readings and notifications, empowering individuals with diabetes to make prompt choices and mitigate health hazards. A prime example is the FreeStyle Libre 2 Plus, introduced in August 2025 by Abbott Laboratories, a US-based healthcare entity. This device provides ongoing minute-by-minute glucose measurements sent straight to a compatible smartphone, complemented by optional alerts for fluctuations in glucose levels. It aids in confident self-management of diabetes by delivering automated alerts, insights into past trends, and directional indicators, thereby eliminating the need for regular fingersticks. Operating via near-field communication and Bluetooth, the device is designed for wear for up to 15 days. Furthermore, it allows caregivers to access glucose updates via integrated digital health platforms. This technology contributes to improved patient safety by facilitating rapid interventions and boosts engagement through continuous insights that inform daily health decisions.

    Which Firms Are Influencing Competition In The Diabetes Care Devices Market?

    Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited

    Get The Full Diabetes Care Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

    Which Region Accounts For The Largest Portion Of The Diabetes Care Devices Market?

    North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Diabetes Care Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=3609&type=smp

    Browse Through More Reports Similar to the Global Diabetes Care Devices Market 2026, By The Business Research Company

    Pet Diabetes Care Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

    Insulin Delivery Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

    Digital Diabetes Management Market Report 2026

    https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Treatment Devices Market Outlook 2026–2030 Featuring Innovation Trends and Competitive Landscape

    Diabetes Treatment Devices Market Outlook 2026–2030 Featuring Innovation Trends and Competitive Landscape

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Is The Forecasted Market Value Of The Diabetes Treatment Devices Market Across 2026–2030?

    The diabetes treatment devices market size has shown substantial growth in recent years. This market is forecasted to increase from $12.34 billion in 2025 to $13.11 billion in 2026, advancing at a compound annual growth rate (CAGR) of 6.2%. The expansion observed in prior periods can be attributed to factors like the reliance on traditional blood glucose meters, limited understanding of self-monitoring devices, the expansion of hospital and diagnostic center infrastructure, a rising incidence of diabetes, and the widespread adoption of standard lancets and testing strips.

    The diabetes treatment devices market is projected to undergo significant growth in the upcoming years. It is forecast to achieve a valuation of $16.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This anticipated expansion during the forecast period is primarily driven by the advancement of smart insulin pens and pumps, the increasing acceptance of real-time continuous glucose monitoring, its integration with smartphones and wearable technologies, the rise in remote patient monitoring programs, and the growth of diabetes clinics along with online distribution channels. Prominent trends expected in this period include the wider adoption of continuous glucose monitoring devices, a growing preference for intelligent insulin delivery systems, an increase in homecare and remote patient monitoring services, the expansion of wearable and handheld glucometers, and an elevated demand for safety-enhanced lancets and testing strips.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

    Which Market Drivers Are Supporting The Expansion Of The Diabetes Treatment Devices Market?

    The future growth of the diabetes treatment devices market is expected to be propelled by the escalating obesity rates. The obesity rate indicates the proportion of individuals categorized as obese based on their body mass index (BMI). These rising obesity rates primarily result from unhealthy diets high in calories, sugars, and fats, leading to excessive weight gain when not balanced with physical activity. Diabetes treatment devices assist in reducing obesity rates through promoting superior blood sugar control, which in turn supports healthier lifestyle habits and effective weight management. For instance, in September 2024, according to the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, adult obesity rates in 2023 reached 35% or higher in 23 US states, an increase from 22 states in 2022, indicating a worsening obesity trend. Thus, increasing obesity rates are a key driver for the growth of the diabetes treatment devices market.

    What Segmentation Levels Are Considered In The Diabetes Treatment Devices Market?

    The diabetes treatment devices market covered in this report is segmented –

    1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

    3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

    Subsegments:

    1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

    2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

    3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

    4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

    5) By Lancets: Standard Lancets, Safety Lancets

    6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

    7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

    8) By Transmitters: Reusable Transmitters, Disposable Transmitters

    9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

    10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

    What Trends Are Projected To Affect The Diabetes Treatment Devices Market?

    Leading companies operating in the diabetes treatment devices market are concentrating on integrating sophisticated automation technologies, such as automated insulin delivery algorithms, to enhance treatment precision and facilitate continuous glycemic control. These algorithms utilize real-time glucose data from continuous glucose monitoring sensors to automatically adjust basal insulin dosing, thereby helping to maintain glucose levels within the target range with minimal manual intervention. For instance, in April 2023, Medtronic plc, a US-based medical technology company, secured FDA approval for the MiniMed 780G System, an automated insulin delivery technology designed to support individuals with type 1 diabetes by automatically correcting highs and adjusting insulin delivery every five minutes. The system incorporates SmartGuard technology for real-time glucose-responsive insulin adjustments, offers Bluetooth connectivity for mobile monitoring, and provides integrated continuous glucose monitoring support. The MiniMed 780G System improves treatment accuracy, enhances glucose stability, and optimizes day-to-day diabetes management outcomes.

    Which Leading Firms Are Contributing To The Growth Of The Diabetes Treatment Devices Market?

    Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

    Read the full diabetes treatment devices market report here:

    https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

    How Is The Diabetes Treatment Devices Market Distributed Across Key Geographic Regions?

    North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Diabetes Treatment Devices Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

    Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2026, By The Business Research Company

    Pet Diabetes Care Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

    Insulin Delivery Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

    Continuous Glucose Monitoring Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Care Devices Market Forecast 2026–2035 Presenting Market Data Trends and Industry Insights

    Diabetes Care Devices Market Forecast 2026–2035 Presenting Market Data Trends and Industry Insights

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Increase Is Anticipated For The Diabetes Care Devices Market Over The 2026–2030 Period?

    The market size for diabetes care devices has experienced swift expansion recently. This market is projected to expand from $73.91 billion in 2025 to $82.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.3%. Historical growth has been driven by factors such as an increasing worldwide prevalence of diabetes, enhanced accessibility to glucose monitoring technology, the proliferation of outpatient diabetes management, greater recognition of self-monitoring benefits, and the expanding supply of disposable testing products.

    The diabetes care devices market is anticipated to undergo significant expansion in the coming years, reaching **$130.76 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%**. This projected growth is driven by factors such as a rising need for real-time glucose monitoring, the increased uptake of closed-loop insulin systems, the proliferation of digital diabetes management platforms, a heightened focus on individualized diabetes care, and increased healthcare spending on chronic disease management. Noteworthy trends expected during this period include the wider adoption of continuous glucose monitoring devices, an increase in the use of smart insulin delivery systems, the growing integration of mobile health platforms, the expansion of interconnected diabetes management ecosystems, and a stronger emphasis on patient-focused monitoring solutions.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3609&type=smp

    What Underlying Factors Are Accelerating The Growth Of The Diabetes Care Devices Market?

    Higher spending on healthcare is projected to drive the expansion of the diabetes care device market moving ahead. Healthcare expenditures denote the aggregate sum spent on services, products, and activities related to healthcare within a defined period, typically at an individual, community, national, or global level. The growing healthcare expenditures, alongside enhanced access to healthcare services and an uptick in diabetes diagnoses, stimulate increased investments in research and development, fostering advancements in diabetes care devices such as improved glucose monitoring systems, insulin delivery devices, and digital health solutions. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, the National Health Expenditure (NHE) expanded by 7.5% to $4.9 trillion in 2023, or $14,570 per person, and accounted for 17.6% of Gross Domestic Product (GDP). Hospital expenditures increased by 10.4% to $1,519.7 billion in 2023, a faster rate than the 3.2% growth observed in 2022. Consequently, the escalating healthcare expenditure will fuel the future growth of the diabetes care device market.

    How Is The Diabetes Care Devices Market Segmented Across Key Categories?

    The diabetes care devices market covered in this report is segmented –

    1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters

    2) By Type of Expenditure: Public, Private

    3) By Consumable Type: Instruments Or Equipment, Disposables

    4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing

    5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

    Subsegments:

    1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors

    2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens

    3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes

    4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps

    5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges)

    6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters

    7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management

    Which Upcoming Trends Are Expected To Influence The Diabetes Care Devices Market?

    Major companies within the diabetes care devices market are concentrating on developing advanced solutions like real-time glucose monitoring technology to enhance accuracy, convenience, and proactive disease management. This real-time glucose monitoring technology delivers automated continuous glucose readings and alerts, assisting people with diabetes in making timely decisions and reducing health risks. For instance, in August 2025, Abbott Laboratories, a US-based healthcare company, launched the FreeStyle Libre 2 Plus. This device features continuous minute-by-minute glucose readings transmitted directly to a compatible smartphone, complete with optional alarms for low or high glucose events. It supports confident diabetes self-management by providing automatic alerts, historical trends, and directional arrows, thereby eliminating the need for routine fingersticks. Functioning through near-field communication and Bluetooth connectivity, it can be worn for up to 15 days. Moreover, it allows caregivers to receive glucose updates via connected digital health tools. The device improves patient safety by enabling quick interventions and boosts engagement by offering real-time insights that guide daily health choices.

    Who Are The Dominant Players Shaping The Diabetes Care Devices Market Landscape?

    Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited

    Read the full diabetes care devices market report here:

    https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

    Which Region Is Projected To Dominate The Diabetes Care Devices Market During The Forecast Period?

    North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Diabetes Care Devices Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3609&type=smp

    Browse Through More Reports Similar to the Global Diabetes Care Devices Market 2026, By The Business Research Company

    Pet Diabetes Care Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

    Insulin Delivery Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

    Digital Diabetes Management Market Report 2026

    https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Diabetes Treatment Devices Market Report 2026–2035: Key Forecasts and Growth Areas

    Global Diabetes Treatment Devices Market Report 2026–2035: Key Forecasts and Growth Areas

    Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

    How is the Diabetes Treatment Devices Market size predicted to change over the forecast window of 2026–2035?

    The market for diabetes treatment devices has shown substantial growth in recent years. It is anticipated to expand from $12.34 billion in 2025 to $13.11 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.2%. This historical growth was influenced by factors such as the prevalence of traditional blood glucose meters, restricted awareness of self-monitoring devices, the expansion of hospital and diagnostic center infrastructure, the rising prevalence of diabetes, and the adoption of standard lancets and testing strips.

    The diabetes treatment devices market is projected to experience robust expansion over the next few years. It is expected to reach $16.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This projected growth can be attributed to the development of smart insulin pens and pumps, increasing adoption of real-time continuous glucose monitoring, integration with smartphones and wearable devices, expanding remote patient monitoring programs, and the growth of diabetes clinics and online distribution channels. Prominent trends anticipated during this period include the growing uptake of continuous glucose monitoring devices, a rising preference for smart insulin delivery systems, an increase in homecare and remote patient monitoring, the expansion of wearable and handheld glucometers, and a heightened demand for safety-enhanced lancets and testing strips.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

    Which Drivers Are Contributing To The Expansion Of The Diabetes Treatment Devices Market?

    The future growth of the diabetes treatment devices market is anticipated to be propelled by increasing obesity rates. An obesity rate refers to the proportion of individuals classified as obese based on their body mass index (BMI). These rising obesity rates are primarily attributed to unhealthy diets high in calories, sugars, and fats, which lead to excessive weight gain when not balanced with physical activity. Diabetes treatment devices contribute to reducing obesity rates by fostering better blood sugar control, thereby supporting healthier lifestyle habits and weight management. For instance, in September 2024, the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, reported that in 2023, adult obesity rates reached 35% or higher in 23 US states, an increase from 22 states in 2022, signaling a worsening obesity trend. Thus, increasing obesity rates are driving the growth of the diabetes treatment devices market.

    What Segment Categories Are Covered In The Diabetes Treatment Devices Market?

    The diabetes treatment devices market covered in this report is segmented –

    1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

    3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

    Subsegments:

    1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

    2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

    3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

    4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

    5) By Lancets: Standard Lancets, Safety Lancets

    6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

    7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

    8) By Transmitters: Reusable Transmitters, Disposable Transmitters

    9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

    10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

    What Trends Are Reshaping The Dynamics Of The Diabetes Treatment Devices Market?

    Leading companies in the diabetes treatment devices market are emphasizing the integration of sophisticated automation technologies, such as automated insulin delivery algorithms, to improve treatment precision and achieve continuous glycemic control. These algorithms utilize real-time glucose data from continuous glucose monitoring sensors to autonomously adjust basal insulin dosing, aiding in the maintenance of glucose levels within the target range with minimal manual oversight. For example, in April 2023, Medtronic plc, a US-based medical technology company, obtained FDA approval for the MiniMed 780G System, an automated insulin delivery technology crafted to assist individuals with type 1 diabetes by automatically rectifying high glucose levels and adjusting insulin delivery every five minutes. The system is equipped with SmartGuard technology for insulin adjustments that respond to real-time glucose, features bluetooth connectivity for mobile monitoring, and provides integrated continuous glucose monitoring support. The MiniMed 780G System enhances treatment accuracy, glucose stability, and daily diabetes management outcomes.

    Which Key Players Are Driving Competition In The Diabetes Treatment Devices Market?

    Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

    How Does The Diabetes Treatment Devices Market Perform Across Major Global Regions?

    North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Diabetes Treatment Devices Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

    Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2026, By The Business Research Company

    Pet Diabetes Care Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

    Insulin Delivery Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

    Continuous Glucose Monitoring Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

  • Diabetes Care Devices Market 2026–2030: Forecast, Innovation, and Competitive Trends

    Diabetes Care Devices Market 2026–2030: Forecast, Innovation, and Competitive Trends

    Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

    What market expansion outlook does the Diabetes Care Devices Market show for the 2026–2030 period?

    The diabetes care devices market has seen substantial growth recently. Projections indicate it will expand from $73.91 billion in 2025 to $82.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.3%. This historic growth is largely attributable to factors including the rising global prevalence of diabetes, improved access to glucose monitoring devices, the expansion of outpatient diabetes care, increased awareness regarding self-monitoring practices, and the growing availability of disposable testing supplies.

    The diabetes care devices market size is poised for substantial expansion in the coming years. It is projected to reach $130.76 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.3%. This growth during the forecast period stems from factors such as increasing demand for real-time glucose monitoring, rising adoption of closed-loop insulin systems, the expansion of digital diabetes management platforms, a growing emphasis on personalized diabetes care, and increasing healthcare investments in chronic disease management. Prominent trends for the forecast period encompass increasing adoption of continuous glucose monitoring devices, rising use of smart insulin delivery systems, growing integration of mobile health platforms, expansion of connected diabetes management ecosystems, and an enhanced focus on patient-centric monitoring solutions.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3609&type=smp

    What Drivers Are Shaping The Development Of The Diabetes Care Devices Market?

    The expansion of the diabetes care device market is anticipated to be propelled by increasing healthcare expenditures in the future. Healthcare expenditures denote the overall funds directed towards services, products, and activities related to healthcare within a specific timeframe, often assessed at individual, community, national, or global levels. The confluence of rising healthcare spending, enhanced access to healthcare services, and a growing number of diabetes diagnoses stimulates greater investments in research and development. This surge in investment leads to advancements in diabetes care devices, including improved glucose monitoring systems, insulin delivery devices, and digital health solutions. For instance, data from June 2025, released by the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, reported that National Health Expenditure (NHE) increased by 7.5% to $4.9 trillion in 2023, or $14,570 per person, constituting 17.6% of Gross Domestic Product (GDP). Hospital expenditures rose by 10.4% to $1,519.7 billion in 2023, a faster rate compared to the 3.2% growth seen in 2022. Therefore, the ongoing rise in healthcare expenditure is expected to be a significant driver for the growth of the diabetes care device market in the coming period.

    Which Segments Are Contributing To The Growth Of The Diabetes Care Devices Market?

    The diabetes care devices market covered in this report is segmented –

    1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters

    2) By Type of Expenditure: Public, Private

    3) By Consumable Type: Instruments Or Equipment, Disposables

    4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing

    5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

    Subsegments:

    1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors

    2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens

    3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes

    4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps

    5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges)

    6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters

    7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management

    How Are New Market Trends Shaping The Landscape Of The Diabetes Care Devices Market?

    Leading firms within the diabetes care devices market are concentrating on creating sophisticated solutions, particularly real-time glucose monitoring technology, to boost precision, ease of use, and effective disease prevention. This real-time glucose monitoring system delivers automated, ongoing glucose data and warnings, assisting individuals with diabetes in making prompt choices and mitigating potential health hazards. As an illustration, in August 2025, the US-based healthcare provider Abbott Laboratories introduced its FreeStyle Libre 2 Plus, which offers uninterrupted minute-by-minute glucose measurements sent directly to a linked smartphone, complemented by optional alerts for elevated or diminished glucose levels. This device facilitates confident self-management of diabetes by providing automated notifications, insights into past trends, and directional indicators, eliminating the need for regular finger-prick tests. Utilizing near-field communication and Bluetooth, the sensor can be worn for a period of up to 15 days. Furthermore, it allows caregivers to access glucose information through integrated digital health applications. Ultimately, the system contributes to improved patient safety by enabling rapid responses and fosters greater involvement by delivering immediate insights that inform everyday health decisions.

    Who Are The Top-Performing Companies In The Diabetes Care Devices Market In Recent Years?

    Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

    Which Region Is Anticipated To See The Fastest Growth In The Diabetes Care Devices Market?

    North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Diabetes Care Devices Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3609&type=smp

    Browse Through More Reports Similar to the Global Diabetes Care Devices Market 2026, By The Business Research Company

    Pet Diabetes Care Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

    Insulin Delivery Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

    Digital Diabetes Management Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company